youtube_live
Q3 2026 earnings • released • EPS beat +15,81% • Revenue beat +3,88%
See resultschevron_right
ZTS:NYSE
Zoetis Inc
USD 82,11
arrow_downward
-7,93%(-7,07) 1D
USD 81,19
arrow_downward
-1,12% (-0,92)todayPre-market
Closed: 5 Nov., 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
USD 84,87
High
USD 88,74
Low
USD 81,54
Mkt. cap
33,93 mjd
Avg. vol.
4,12 m
Volume
5,16 k
Dividend
2,58%
Quarterly dividend
USD 0,53
Ex-dividend date
30 Okt. 2026
P/E ratio
13,51
52-wk high
USD 132,49
52-wk low
USD 68,77
EPS
USD 6,08
Beta
0,67
Shares outstanding
413,22 m
No. of employees
14 k
Open
USD 84,87
High
USD 88,74
Low
USD 81,54
Mkt. cap
33,93 mjd
Avg. vol.
4,12 m
Volume
5,16 k
Dividend
2,58%
Quarterly dividend
USD 0,53
Ex-dividend date
30 Okt. 2026
P/E ratio
13,51
52-wk high
USD 132,49
52-wk low
USD 68,77
EPS
USD 6,08
Beta
0,67
Shares outstanding
413,22 m
No. of employees
14 k
News stories
From web sources and news partners
Seeking Alpha
·
4 uur gelede
Zoetis Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:ZTS) 2026-11-06
Investor's Business Daily
·
14 uur gelede
No Greyhounds Here: Pet-Health Titan Brakes 30% Sprint
Benzinga
·
14 uur gelede
Republican Senator Who Won Reelection Is Selling Magnificent Seven Stocks: Here Are the Trades
Zacks
·
17 uur gelede
ZTS Q3 Earnings Top Estimates, 2026 Profit Outlook Improves, Stock Up
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14,5 k
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websitezoetis.com